Bellevue Life Sciences Acquisition Corp. (BLAC)

Bellevue Life Sciences Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price

Company Description

Bellevue Life Sciences Acquisition is a newly organized blank check company incorporated in Delaware and formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.

We intend to focus our search on companies in the healthcare industry, more specifically in the biotechnology sector. We are focused on companies developing the next generation of biologics which include therapeutic antibodies, engineered protein and enzyme drugs, cellular therapies, engineered viruses and bacteria, and DNA- and RNA-modifying technologies, using advanced molecular biology and biochemistry.

We will consider companies with pipeline programs in clinical “Proof-of-Concept” studies (often from Phase 1 to 2a) to develop novel medicines to address diseases which cannot yet be cured or sufficiently managed.

Bellevue Life Sciences Acquisition Corp.
Country United States
Founded 2020
Industry Blank Check / SPAC
CEO Kuk Hyoun Hwang

Contact Details

Address:
10900 NE 4th Street, Suite 2300
Bellevue, WA 98004
United States
Phone (425) 635-7700

Stock Details

Ticker Symbol BLAC
Exchange NASDAQ
Reporting Currency US Dollars
IPO Price $10.00
CIK Code 1840425

Key Executives

Name Position
Kuk Hyoun Hwang Chief Executive Officer and Director
David J. Yoo Chief Financial Officer
Jun Chul Whang Director
Steven Reed Director nominee and nominee for Chairman of the Board

Latest SEC Filings

Date Type Title
May 16, 2022 CERT Certification by an exchange approving securities for listing
May 13, 2022 S-1/A General form for registration of securities under the Securities Act of 1933
May 11, 2022 8-A12B Registration of securities [Section 12(b)]
May 10, 2022 S-1/A General form for registration of securities under the Securities Act of 1933
Apr 29, 2022 S-1 General form for registration of securities under the Securities Act of 1933
Nov 16, 2021 DRS/A Draft Registration Statement
Nov 5, 2021 DRS/A Draft Registration Statement
Mar 12, 2021 DRS Draft Registration Statement